[Mental confusion from interaction of a proton-pump inhibitor with benzodiazepines: 3 cases].
Andre
M
M
Fialip
J
J
Zenut
M
M
Aumaitre
O
O
Eschalier
A
A
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D001960:Bromazepam / Q000009:adverse effects; D003221:Confusion / Q000139:chemically induced* / Q000523:psychology*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives; D054328:Proton Pump Inhibitors
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D014151:Anti-Anxiety Agents; D000897:Anti-Ulcer Agents; D004791:Enzyme Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D009853:Omeprazole; D001960:Bromazepam